Highlights

  • Australian Clinical Labs Ltd (ASX: ACL) closed at $2.38 on August 7, 2026.
  • The stock recorded a decline of approximately 1.25 percent for the session.
  • Shares traded within an intraday range of $2.35 to $2.41.
  • Market capitalisation stood at approximately $443.92 million.
  • Trading volume reached 470,832 shares during the session.

Australian Clinical Labs Ltd (ASX: ACL) shares closed at $2.38 on August 7, 2026, after recording a decline of approximately 1.25 percent during the session. The stock traded within an intraday range of $2.35 to $2.41, while the broader S&P/ASX 200 Health Care Index ended lower after declining 0.92 percent.

Australian Clinical Labs Share Price Movement on August 7, 2026

The data reviewed showed that Australian Clinical Labs shares recorded a decline of approximately 1.25 percent during the session. The stock traded between an intraday low of $2.35 and a high of $2.41 before closing at $2.38.

Daily share price movements can be influenced by company-specific developments, market participation, sector sentiment and broader market conditions. The session’s movement reflects short-term trading activity and should be considered alongside longer-term performance trends.

Trading Volume and Market Capitalisation

Trading volume for Australian Clinical Labs reached 470,832 shares during the session. Based on the closing share price, the company’s market capitalisation stood at approximately $443.92 million.

The trading activity reflected market participation during the session, while the company’s market capitalisation placed Australian Clinical Labs among the mid-sized companies within the ASX health care sector.

One-Year Share Price Performance

Over the trailing one-year period, Australian Clinical Labs recorded a decline of approximately 15.90 percent based on the data reviewed.

Health care service companies can experience share price movements over time due to company-specific developments, operational factors, sector conditions and broader market sentiment.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) closed at 27,976.2 points on August 7, 2026, down 259.3 points or 0.92 percent.

The index recorded a day high of 28,235.5 points and a day low of 27,808.8 points, compared with a previous close of 28,235.5 points. Over the past 52 weeks, the index traded between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.44 percent.

Individual health care stocks can record movements that differ from the broader index due to company-specific factors, trading volumes and changes in investor participation.

About Australian Clinical Labs Ltd

Australian Clinical Labs Ltd is listed on the ASX under the ticker code ACL and operates within the health care sector.

The company provides pathology services, and share price activity can be influenced by company-specific developments, industry conditions, regulatory factors and broader market movements affecting health care businesses.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Australian Clinical Labs’ market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the session, while market capitalisation reflects the market value based on the closing share price and shares on issue. Daily share price movements represent activity during a specific trading period and do not necessarily indicate longer-term performance.

Conclusion

Australian Clinical Labs Ltd (ASX: ACL) shares closed at $2.38 on August 7, 2026, after recording a decline of approximately 1.25 percent during the session. The stock traded within a range of $2.35 to $2.41, with trading volume of 470,832 shares and market capitalisation of approximately $443.92 million.

The broader S&P/ASX 200 Health Care Index closed lower at 27,976.2 points, down 0.92 percent. Over the trailing one-year period, Australian Clinical Labs recorded a decline of approximately 15.90 percent based on the data reviewed.